Epigenetic Therapy as a Putative Molecular Target to Modulate B Cell Biology and Behavior in the Context of Immunological Disorders
Histone Deacetylase- (HDAC-) dependent epigenetic mechanisms have been widely explored in the last decade in different types of malignancies in preclinical studies. This effort led to the discovery and development of a range of new HDAC inhibitors (iHDAC) with different chemical properties and selec...
Main Authors: | Thayse Pinheiro da Costa, Marcia Cury El-Cheikh, Katia Carneiro |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2020-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2020/1589191 |
Similar Items
-
The epigenome as a putative target for skin repair: the HDAC inhibitor Trichostatin A modulates myeloid progenitor plasticity and behavior and improves wound healing
by: Mariana Cabanel, et al.
Published: (2019-07-01) -
Metabolism and Epigenetic Interplay in Cancer: Regulation and Putative Therapeutic Targets
by: Vera Miranda-Gonçalves, et al.
Published: (2018-10-01) -
Cryoablation: physical and molecular basis with putative immunological consequences
by: John G. Baust, et al.
Published: (2019-11-01) -
Corrigendum: Metabolism and Epigenetic Interplay in Cancer: Regulation and Putative Therapeutic Targets
by: Vera Miranda-Gonçalves, et al.
Published: (2019-09-01) -
A Novel Role of Silibinin as a Putative Epigenetic Modulator in Human Prostate Carcinoma
by: Ioannis Anestopoulos, et al.
Published: (2016-12-01)